𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma

✍ Scribed by Jeng, Jen-Eing; Tsai, Meng-Feng; Tsai, Hey-Ru; Chuang, Lea-Yea; Lin, Zu-Yau; Hsieh, Min-Yuh; Chen, Shinn-Chern; Chuang, Wan-Lung; Wang, Liang-Yen; Yu, Min-Lung; Dai, Chia-Yen; Tsai, Jung-Fa

Book ID
125384039
Publisher
S. Karger AG
Year
2013
Tongue
English
Weight
443 KB
Volume
35
Category
Article
ISSN
1010-4283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum transforming growth factor α level
Serum transforming growth factor α level as a marker of hepatocellular carcinoma complicating cirrhosis
✍ Tomoaki Tomiya; Kenji Fujiwara 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 1 views

Transforming growth factor u (TGFn) is alleged to play a role in malignant progression as well as normal cell growth in an autocrine manner and its serum levels have been reported to increase during this progression. Most hepatocellular carcinomas (HCC) develop in cirrhotic livers in which hepatocyt

Hepatocyte growth factor, transforming g
Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinoma
✍ Maryvonne Daveau; Michel Scotte; Arnaud François; Cédric Coulouarn; Gilles Ros; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract A change in the balance between proliferation and apoptosis in the course of hepatocellular carcinoma (HCC) development and progression has been suspected. We wanted to identify related genes whose mRNA levels could provide markers of severity and prognosis after resection. The extent o